BridgeMD
New treatment option for Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Official title Study on the Use of Lateral Decubitus Position in Left Breast Cancer Patients Undergoing Adjuvant Radiotherapy
ClinicalTrials.gov ID: NCT06902051
What this study is testing
- What it's testing
- A Prospective Study on the Application of Lateral Decubitus Position in Patients with Left Breast Cancer Undergoing Adjuvant Radiotherapy
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70, women only
You may be able to join if
- Voluntary signing of the informed consent form
- Female patients aged 18-70 years
- Newly diagnosed left-sided breast cancer confirmed by histopathology
- No evidence of distant metastasis
- Undergoing modified radical mastectomy or breast-conserving surgery
You likely can't join if
- Bilateral breast cancer at diagnosis
- History of breast reconstruction or implant placement on the affected side
- Prior radiotherapy to the chest or supraclavicular region
- Patients deemed unsuitable for the study based on the investigator's judgment
See the full eligibility criteria
- Voluntary signing of the informed consent form
- Female patients aged 18-70 years
- Newly diagnosed left-sided breast cancer confirmed by histopathology
- No evidence of distant metastasis
- Undergoing modified radical mastectomy or breast-conserving surgery
- ECOG performance status of 0, 1, or 2
- Tolerance to radiotherapy
- Radiation field covering the entire left breast/chest wall ± regional lymphatic drainage area
- Bilateral breast cancer at diagnosis
- History of breast reconstruction or implant placement on the affected side
- Prior radiotherapy to the chest or supraclavicular region
- Patients deemed unsuitable for the study based on the investigator's judgment
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong Provinse, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong Provinse, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.